spacer
home > pmps > spring 2017 > easy access
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Easy Access

Times have changed dramatically in the past 10 years, with external cost pressure, patent losses, dried-up R&D pipelines and the rise of biosimilars forcing Big Pharma to rethink its business models. All of a sudden, the cost of packaging drugs can make a telling difference to the bottom line, or even mean the difference between winning a tender or not.

All of this comes in an environment where patients are hoping for greater protection from external contamination, counterfeits and their children accessing dangerous drugs, and payers are expecting the industry to demonstrate the effectiveness of their products. But how can pharmaceutical companies balance the conflicting needs of lower cost and higher protection?

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Colin Reed is Marketing and Strategy Director for Amcor Flexibles Global Pharma and Medical EMEA businesses. He has 19 years of experience in pharmaceutical packaging and has held previous leadership positions in operations and marketing, including managing businesses in the Asia- Pacific region. Colin holds a Bachelor of Engineering degree and an MBA from Aston University, UK.

Greg Rosati is currently the Healthcare Marketing Director for Amcor Rigid Plastics. He has 24 years of packaging experience – including 15 in healthcare – and has held various leadership roles in product development, sales, marketing and quality systems. Greg holds a BS from Michigan State University, US.
spacer
Colin Reed
spacer
spacer
spacer
Greg Rosati
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Saneca to drive R&D Initiative following €1.5 million funding


More info >>

White Papers

Migration safe pharmaceutical labels improve patient safety

UPM Raflatac

Labels play an invaluable role on pharmaceutical packages. Pharmaceutical companies should only use labels that meet low-leachability and extraction requirements. Labels that are not migration safe, e.g. create leachable chemical compounds, may fail testing and result in significant launch delays or costly recalls. This white paper presents how pharmaceutical companies can ensure that the final label constructions achieve their business, regulatory and patient safety goals.
More info >>

 
Industry Events

Pharmaceutical Microbiology East Coast

13-14 November 2017, Renaissance Woodbridge Hotel, New Jersey

Drawing on from the huge success of SMi’s Pharmaceutical Microbiology event series, SMi is delighted to announce the launch of Pharmaceutical Microbiology East Coast. Being the eighth in its series, this event will take place in New Jersey, USA, on November 13th and 14th 2017. Aimed at Microbiologists, Quality Control and Quality Assurance Managers, Pharmaceutical Microbiology East Coast 2017 will address the best practices for rapid microbial and sterility testing and tackle the challenges of contamination control.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement